Search

Abstract Multiple emulsions are usually stabilized by amphiphilic molecules that combine the chemical characteristics of the different phases in contact. When one phase is a liquid crystal (LC), the choice of stabilizer also determines its configuration, but conventional wisdom assumes that the orientational order of the LC has no impact on the stabilizer. Here we show that, for the case of amphiphilic polymer stabilizers, this impact can be considerable. The mode of interaction between stabilizer and LC changes if the latter is heated close to its isotropic state, initiating a feedback loop that reverberates on the LC in form of a complete structural rearrangement. We utilize this phenomenon to dynamically tune the configuration of cholesteric LC shells from one with radial helix and spherically symmetric Bragg diffraction to a focal conic domain configuration with highly complex optics. Moreover, we template photonic microparticles from the LC shells by photopolymerizing them into solids, retaining any selected LC-derived structure. Our study places LC emulsions in a new light, calling for a reevaluation of the behavior of stabilizer molecules in contact with long-range ordered phases, while also enabling highly interesting photonic elements with application opportunities across vast fields.

Cholesteric Spherical Reflectors (CSRs) are omnidirectional retroreflectors that are selective in circular polarization and wavelength, enabling human-invisible fiducial markers for applications in robotics, augmented reality, anti-counterfeiting, circular economy and more

While structural color is a powerful means of obtaining saturated and durable pigments that minimize absorption, scattering, and negative environmental impact, appearing naturally in animals and plants as well as in carefully designed artificial composites, it is fundamentally limited to spectral colors, leaving white and other mixed colors elusive. It also normally suffers from a strong viewing angle dependence, making color definition difficult. Herein, it is demonstrated that these challenges can be overcome by using cholesteric spherical reflectors (CSRs), spheres of polymerized cholesteric liquid crystal with radial alignment of the self‐assembled helical structure. Exhibiting omnidirectional selective retroreflectivity of well‐defined color, CSRs are discrete “packages” of structural color. This allows them to be used as pixels for generating nonspectral colors, following the principle of digital displays. A method of creating densely packed monolayers of CSRs with red (R), green (G), and blue (B) retroreflection is developed. Mixing them in equal proportions gives a white surface. By embedding the CSRs in an index matching transparent medium, nonselective specular reflections and scattering are avoided. The approach can be used to create arbitrary colors, including nonspectral ones, without any absorption or nonselective scattering, opening doors to decorating surfaces as desired while minimizing light loss.

With the development of medicine, our research on Alzheimer's disease (AD) has been further deepened, but the mechanism of its occurrence and development has not been fully revealed, and there is currently no effective treatment method. Several studies have shown that apolipoprotein AI (ApoA-I) can affect the occurrence and development of Alzheimer's disease by binding to amyloid β (Aβ). However, the association between circulating levels of ApoA-I and AD remains controversial. We conducted a meta-analysis of 18 studies published between 1992 and 2017 to determine whether the ApoA-I levels in the blood and cerebrospinal fluid (CSF) are abnormal in AD. Literatures were searched in PubMed, EMBASE and Web of Science databases without language limitations. A pooled subject sample including 1,077 AD patients and 1,271 healthy controls (HCs) was available to assess circulating ApoA-I levels; 747 AD patients and 680 HCs were included for ApoA-I levels in serum; 246 AD patients and 456 HCs were included for ApoA-I levels in plasma; 201 AD patients and 447 HCs were included for ApoA-I levels in CSF. It was found that serum and plasma levels of ApoA-I were significantly reduced in AD patients compared with HCs {[standardized mean difference (SMD) = −1.16; 95% confidence interval (CI) (−1.72, −0.59); P = 0.000] and [SMD = −1.13; 95% CI (−2.05, −0.21); P = 0.016]}. Patients with AD showed a tendency toward higher CSF ApoA-I levels compared with HCs, although this difference was non-significant [SMD = 0.20; 95% CI (−0.16, 0.56); P = 0.273]. In addition, when we analyzed the ApoA-I levels of serum and plasma together, the circulating ApoA-I levels in AD patients was significantly lower [SMD = −1.15; 95% CI (−1.63, −0.66); P = 0.000]. These results indicate that ApoA-I deficiency may be a risk factor of AD, and ApoA-I has the potential to serve as a biomarker for AD and provide experimental evidence for diagnosis of AD.Systematic Review Registration: PROSPERO, identifier: 325961.